No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 21.390
- 0.0000.00%
Trading Jul 22 16:00 ET
550.22MMarket Cap-165813P/E (TTM)
0.000High0.000Low8.39KVolume21.010Open21.390Pre Close0.00Turnover0.11%Turnover Ratio1944.55P/E (Static)25.72MShares22.00052wk High-7.28P/B158.79MFloat Cap13.27052wk Low--Dividend TTM7.42MShs Float22.000Historical High--Div YieldTTM0.00%Amplitude13.270Historical Low0.000Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
Express News | Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
Contineum Therapeutics Sets Executive Severance Plan
Stifel Nicolaus Sticks to Its Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)
Express News | Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
Comments
$Contineum Therapeutics(CTNM.US$what am i missing?
$Contineum Therapeutics(CTNM.US$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
